Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy-Reference-Cited by-同舟云学术

Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy

Published:2018-07 Issue:4 Volume:12 Page:972-980.e1
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Hartgers Merel L.,Besseling Joost,Stroes Erik S.,Wittekoek Janneke,Rutten Joost H.W.,de Graaf Jacqueline,Visseren Frank L.J.,Imholz Ben P.M.,Roeters van Lennep Jeanine E.,Huijgen Roeland,Kastelein John J.P.,Hovingh G. Kees

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference47 articles.

1. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome;Sjouke;Eur Heart J,2015

2. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen general population study estimated a prevalence of 1 in 217;Benn;Eur Heart J,2016

3. Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants;Huijgen;Eur Heart J,2012

4. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication;Benn;J Clin Endocrinol Metab,2012

5. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia;Khera;J Am Coll Cardiol,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN;American Heart Journal;2024-08

2. Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery;Biomaterials;2024-07

3. A retrospective study of people with familial hypercholesterolaemia in a Belgian lipid clinic;Acta Cardiologica;2023-10-26

4. Recent advances in the management and implementation of care for familial hypercholesterolaemia;Pharmacological Research;2023-08

5. A Scoping Review of Approaches for the Detection and Management of Familial Hypercholesterolaemia in Primary Care;2023-07-13